Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-13

FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic pravastatin sodium product by Aurobindo Pharma Limited, authorizing its continued marketing. This repr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pravastatin Sodium (pravastatin sodium)

Snippet

SUPPL AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)